Acrodermatitis chronica atrophicans epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Region) |
|||
| Line 34: | Line 34: | ||
===Region=== | ===Region=== | ||
*The majority of [[acrodermatitis chronica atrophicans]] cases are reported in northern, central and eastern Europe. <ref name="pmid30311153">{{cite journal| author=Khalili M, Wong RJ| title=Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. | journal=Dig Dis Sci | year= 2018 | volume= 63 | issue= 12 | pages= 3250-3252 | pmid=30311153 | doi=10.1007/s10620-018-5316-9 | pmc=6436636 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30311153 }} </ref><ref name="pmid8221518">{{cite journal| author=Asbrink E| title=Acrodermatitis chronica atrophicans. | journal=Clin Dermatol | year= 1993 | volume= 11 | issue= 3 | pages= 369-75 | pmid=8221518 | doi=10.1016/0738-081x(93)90092-q | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8221518 }} </ref> | *The majority of [[acrodermatitis chronica atrophicans]] cases are reported in northern, central and eastern Europe (most commonly in countries bordering the Baltic Sea). <ref name="pmid30311153">{{cite journal| author=Khalili M, Wong RJ| title=Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. | journal=Dig Dis Sci | year= 2018 | volume= 63 | issue= 12 | pages= 3250-3252 | pmid=30311153 | doi=10.1007/s10620-018-5316-9 | pmc=6436636 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30311153 }} </ref><ref name="pmid8221518">{{cite journal| author=Asbrink E| title=Acrodermatitis chronica atrophicans. | journal=Clin Dermatol | year= 1993 | volume= 11 | issue= 3 | pages= 369-75 | pmid=8221518 | doi=10.1016/0738-081x(93)90092-q | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8221518 }} </ref><ref name="pmid32512846">{{cite journal| author=Scott JD| title=Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada. | journal=Healthcare (Basel) | year= 2020 | volume= 8 | issue= 2 | pages= | pmid=32512846 | doi=10.3390/healthcare8020157 | pmc=7349802 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32512846 }} </ref> | ||
*Lately few cases of [[acrodermatitis chronica atrophicans]] have been reported in the United States which were associated to [[Lyme disease]] (besides European immigrants). <ref name="pmid30311153">{{cite journal| author=Khalili M, Wong RJ| title=Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. | journal=Dig Dis Sci | year= 2018 | volume= 63 | issue= 12 | pages= 3250-3252 | pmid=30311153 | doi=10.1007/s10620-018-5316-9 | pmc=6436636 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30311153 }} </ref><ref name="pmid33550695">{{cite journal| author=Ogrinc K, Maraspin V, Lusa L, Cerar Kišek T, Ružić-Sabljić E, Strle F| title=Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. | journal=J Intern Med | year= 2021 | volume= | issue= | pages= | pmid=33550695 | doi=10.1111/joim.13266 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33550695 }} </ref> | *Lately few cases of [[acrodermatitis chronica atrophicans]] have been reported in the United States which were associated to [[Lyme disease]] (besides European immigrants). <ref name="pmid30311153">{{cite journal| author=Khalili M, Wong RJ| title=Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. | journal=Dig Dis Sci | year= 2018 | volume= 63 | issue= 12 | pages= 3250-3252 | pmid=30311153 | doi=10.1007/s10620-018-5316-9 | pmc=6436636 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30311153 }} </ref><ref name="pmid33550695">{{cite journal| author=Ogrinc K, Maraspin V, Lusa L, Cerar Kišek T, Ružić-Sabljić E, Strle F| title=Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. | journal=J Intern Med | year= 2021 | volume= | issue= | pages= | pmid=33550695 | doi=10.1111/joim.13266 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33550695 }} </ref> | ||
*Few cases have been observed in Canada recently.<ref name="pmid32512846">{{cite journal| author=Scott JD| title=Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada. | journal=Healthcare (Basel) | year= 2020 | volume= 8 | issue= 2 | pages= | pmid=32512846 | doi=10.3390/healthcare8020157 | pmc=7349802 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32512846 }} </ref> | |||
==References== | ==References== | ||
Revision as of 15:27, 14 June 2021
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics |
|
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Acrodermatitis chronica atrophicans epidemiology and demographics in the news |
|
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics |
|
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Acrodermatitis chronica atrophicans epidemiology and demographics in the news |
|
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- Only 10% of lyme disease cases in European population have been presented with arodermatitis chronica atrophicans. [1]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- The prevalence of acrodermatitis chronica atrophicans is estimated to include 10% of cases with lyme disease in Europe.[2]
Case-fatality rate/Mortality rate
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- The incidence of acrodermatitis chronica atrophicans increases with age. [3]
- Acrodermatitis chronica atrophicans commonly affects individuals in range of 40 to 70 years old.[3]
- There are few case reports on children who are diagnosed with acrodermatitis chronica atrophicans.[4]
- In a study done on 693 patients with acrodermatitis chronica atrophicans median age of disease has been estimated 64 years old. [5]
Race
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Acrodermatitis chronica atrophicans affects women more than men.[3][2]
- Based on several studies female predominance has been reported approximately 65-80 % in acrodermatitis chronica atrophicans patient.[6][7][8]
Region
- The majority of acrodermatitis chronica atrophicans cases are reported in northern, central and eastern Europe (most commonly in countries bordering the Baltic Sea). [3][9][10]
- Lately few cases of acrodermatitis chronica atrophicans have been reported in the United States which were associated to Lyme disease (besides European immigrants). [3][5]
- Few cases have been observed in Canada recently.[10]
References
- ↑ Smetanick MT, Zellis SL, Ermolovich T (2010). "Acrodermatitis chronica atrophicans: a case report and review of the literature". Cutis. 85 (5): 247–52. PMID 20540415.
- ↑ 2.0 2.1 "StatPearls". 2021. PMID 33085436 Check
|pmid=value (help). - ↑ 3.0 3.1 3.2 3.3 3.4 Khalili M, Wong RJ (2018). "Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net". Dig Dis Sci. 63 (12): 3250–3252. doi:10.1007/s10620-018-5316-9. PMC 6436636. PMID 30311153.
- ↑ Nadal, D; Gundelfinger, R; Flueler, U; Boltshauser, E (1988). "Acrodermatitis chronica atrophicans". Archives of Disease in Childhood. 63 (1): 72–74. doi:10.1136/adc.63.1.72. ISSN 0003-9888.
- ↑ 5.0 5.1 Ogrinc K, Maraspin V, Lusa L, Cerar Kišek T, Ružić-Sabljić E, Strle F (2021). "Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients". J Intern Med. doi:10.1111/joim.13266. PMID 33550695 Check
|pmid=value (help). - ↑ THYRESSON N (1949). "The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer)". Acta Derm Venereol. 29 (6): 572–621. PMID 18140373.
- ↑ Asbrink E, Hovmark A, Olsson I (1986). "Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients". Zentralbl Bakteriol Mikrobiol Hyg A. 263 (1–2): 253–61. doi:10.1016/s0176-6724(86)80128-6. PMID 3577484.
- ↑ Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Wilske B; et al. (1988). "Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans". Ann N Y Acad Sci. 539: 324–45. doi:10.1111/j.1749-6632.1988.tb31867.x. PMID 3056202.
- ↑ Asbrink E (1993). "Acrodermatitis chronica atrophicans". Clin Dermatol. 11 (3): 369–75. doi:10.1016/0738-081x(93)90092-q. PMID 8221518.
- ↑ 10.0 10.1 Scott JD (2020). "Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada". Healthcare (Basel). 8 (2). doi:10.3390/healthcare8020157. PMC 7349802 Check
|pmc=value (help). PMID 32512846 Check|pmid=value (help).